Chirogate International Inc.

Chirogate International, founded in 1999 in Taoyuan, Taiwan, by a group of chemical scientists, is a US FDA-inspected leading manufacturer of prostaglandin active pharmaceutical ingredients (APIs). Specialized in niche-market prostaglandin molecules, it operates 10+ dedicated cGMP production lines and holds over 64 worldwide patents. Supplies Latanoprost, Tafluprost, Travoprost, Misoprostol, and more.